Short Interest in BlackRock Capital Allocation Term Trust (NYSE:BCAT) Grows By 25.0%

BlackRock Capital Allocation Term Trust (NYSE:BCAT) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 640,429 shares, a growth of 25.0% from the November 30th total of 512,203 shares. Based on an average daily trading volume, of 608,344 shares, the short-interest ratio is presently 1.1 days. Approximately 0.6% of the company’s shares are short sold. Approximately 0.6% of the company’s shares are short sold. Based on an average daily trading volume, of 608,344 shares, the short-interest ratio is presently 1.1 days.

BlackRock Capital Allocation Term Trust Trading Down 0.6%

Shares of NYSE BCAT opened at $14.18 on Friday. BlackRock Capital Allocation Term Trust has a fifty-two week low of $12.91 and a fifty-two week high of $15.91. The business’s 50 day moving average price is $14.37 and its 200-day moving average price is $14.72.

BlackRock Capital Allocation Term Trust Cuts Dividend

The firm also recently announced a monthly dividend, which was paid on Wednesday, December 31st. Shareholders of record on Monday, December 22nd were paid a $0.262 dividend. The ex-dividend date was Monday, December 22nd. This represents a c) dividend on an annualized basis and a yield of 22.2%.

Institutional Trading of BlackRock Capital Allocation Term Trust

Large investors have recently made changes to their positions in the stock. AdvisorNet Financial Inc grew its holdings in shares of BlackRock Capital Allocation Term Trust by 83.3% in the second quarter. AdvisorNet Financial Inc now owns 1,947 shares of the company’s stock worth $29,000 after purchasing an additional 885 shares during the last quarter. Keener Financial Planning LLC purchased a new stake in BlackRock Capital Allocation Term Trust in the 3rd quarter valued at about $29,000. Geneos Wealth Management Inc. grew its stake in BlackRock Capital Allocation Term Trust by 341.7% in the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after acquiring an additional 1,582 shares in the last quarter. Red Tortoise LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust during the second quarter worth approximately $33,000. Finally, McIlrath & Eck LLC increased its position in shares of BlackRock Capital Allocation Term Trust by 971.1% during the third quarter. McIlrath & Eck LLC now owns 2,999 shares of the company’s stock worth $44,000 after acquiring an additional 2,719 shares during the period. 36.12% of the stock is owned by hedge funds and other institutional investors.

BlackRock Capital Allocation Term Trust Company Profile

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.